CDH1 and ovarian cancer: Recently, Tang et al. demonstrated that soluble E-cadherin is highly expressed in ovarian cancer patients where soluble E-cadherin is released in the form of exosomes to promote tumor angiogenesis via activation of β-catenin and NF-κB signaling [45].